Cargando…

Thrombin in complex with dabigatran can still interact with PAR‐1 via exosite‐I and instigate loss of vascular integrity

BACKGROUND: Atrial fibrillation (AF) can lead to the loss of microvascular integrity thereby enhancing AF progression. Mechanistically, the pro‐coagulant state that drives the risk of stroke in patients with AF may also play a causal role in microvascular loss. Direct oral anticoagulants (DOACs), th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dólleman, Sophie C., Agten, Stijn M., Spronk, Henri M. H., Hackeng, Tilman M., Bos, Mettine H. A., Versteeg, Henri H., van Zonneveld, Anton Jan, de Boer, Hetty C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	VASCULAR BIOLOGY
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306515/ https://www.ncbi.nlm.nih.gov/pubmed/35037739 http://dx.doi.org/10.1111/jth.15642

Ejemplares similares

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function
por: Yeh, Calvin H., et al.
Publicado: (2016)

The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin
por: Chahal, Gurdeep, et al.
Publicado: (2015)

GpIbα Interacts Exclusively with Exosite II of Thrombin()
por: Lechtenberg, Bernhard C., et al.
Publicado: (2014)

Snakebites and microvesicles: Popping bubbles
por: Bos, Mettine H.A., et al.
Publicado: (2019)

Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)

Exosite Binding in Thrombin: A Global Structural/Dynamic Overview of Complexes with Aptamers and Other Ligands
por: Troisi, Romualdo, et al.
Publicado: (2021)

Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis
por: Wilson, Simon J, et al.
Publicado: (2019)

Dabigatran Monitoring Was Influenced by Thrombin Time Reagent With Different Thrombin Concentrations
por: Xu, Xiaoping, et al.
Publicado: (2019)

Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
por: Grottke, Oliver, et al.
Publicado: (2014)

Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand
por: Boyle, Amanda J, et al.
Publicado: (2013)

Thrombin Generation in the Glasgow Myocardial Infarction Study
por: Smid, Machiel, et al.
Publicado: (2013)

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution
por: Grottke, Oliver, et al.
Publicado: (2019)

Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
Publicado: (2010)

Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
por: Grossmann, Klaus
Publicado: (2021)

Protease-Activated Receptor (PAR)2, but Not PAR1, Is Involved in Collateral Formation and Anti-Inflammatory Monocyte Polarization in a Mouse Hind Limb Ischemia Model
por: van den Hengel, Lisa G., et al.
Publicado: (2013)

Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
por: Honickel, M, et al.
Publicado: (2014)

Probing Functional Heteromeric Chemokine Protein–Protein Interactions through Conformation‐Assisted Oxime Ligation
por: Agten, Stijn M., et al.
Publicado: (2016)

Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice
por: Pingel, Simon, et al.
Publicado: (2014)

The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency
por: Gribkova, Irina V., et al.
Publicado: (2016)

The intestinal microbiome potentially affects thrombin generation in human subjects
por: Mohammed, Yassene, et al.
Publicado: (2019)

Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation
por: Jaffer, Iqbal H, et al.
Publicado: (2015)

Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts
por: Altieri, Paola, et al.
Publicado: (2018)

Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway
por: Ewees, Mohamed Gamal El-Din, et al.
Publicado: (2021)

PAR1 regulation of CXCL1 expression and neutrophil recruitment to the lung in mice infected with influenza A virus
por: Antoniak, Silvio, et al.
Publicado: (2021)

Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
por: Santamaria, Salvatore, et al.
Publicado: (2021)

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
por: van de Berg, Tom W., et al.
Publicado: (2022)

Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay
por: D'Alessandro, Elisa, et al.
Publicado: (2021)

Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner
por: Borissoff, Julian I., et al.
Publicado: (2013)

Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events
por: Loeffen, Rinske, et al.
Publicado: (2016)

Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2)
por: Santamaria, Salvatore, et al.
Publicado: (2015)

Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model
por: Zentai, Christian, et al.
Publicado: (2015)

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study
por: Liu, Zhiyan, et al.
Publicado: (2022)

Dabigatran reduces thrombin-induced neuroinflammation and AD markers in vitro: Therapeutic relevance for Alzheimer's disease
por: Bihaqi, Syed Waseem, et al.
Publicado: (2021)

The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice
por: Buijs, Jeroen T., et al.
Publicado: (2019)

Prothrombin complex concentrate restores haemostasis in a dabigatran anticoagulated polytrauma pig model
por: Honickel, M, et al.
Publicado: (2014)

Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition
por: Cuffaro, Doretta, et al.
Publicado: (2022)

Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes
por: Sommeijer, Dirkje W, et al.
Publicado: (2005)

Endothelial cells instigate sepsis
por: Bashyam, Hema
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5c7hiah73tml7i27eo26u2n9m8